alantolactone

N/A

Report date: 2023/01/31 14:34:01
NME

Base Information

Drug Namealantolactone
Drug Alias NameN/A
ClassificationNatural product/Extract
Mechanisms of ActionNACHT, LRR and PYD domains-containing protein 3 inhibitors
TargetsNACHT, LRR and PYD domains-containing protein 3
Therapy Area/IndicationsAcute Lung InjuryArthritis, Gouty
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesWenzhou Medical University
China Registration ClassN/A

Develop Information

Active CompaniesWenzhou Medical University
Inactive CompaniesN/A
Active IndicationsAcute Lung InjuryArthritis, Gouty
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A